Monograph of Olanzapine
Introduction Olanzapine is a second‑generation (atypical) antipsychotic agent that has become a cornerstone in the management of schizophrenia and bipolar disorder. It…
Topic Archive
Category: Uncategorized
Monograph of Risperidone
Introduction Risperidone is a second‑generation antipsychotic that has become a cornerstone in the management of several neuropsychiatric disorders. Initially approved for schizophrenia,…
Bromocriptine Monograph: Pharmacology & Applications
Introduction Bromocriptine is a synthetic dopamine D₂ receptor agonist initially developed in the 1970s for the treatment of Parkinsonian disorders. Over subsequent…
Monograph of Carbidopa
Introduction Carbidopa is a peripheral aromatic L‑dopa decarboxylase inhibitor that is routinely co‑administered with levodopa to enhance central nervous system delivery of…
Levetiracetam Monograph
Introduction Levetiracetam (LEV) is a second‑generation antiepileptic agent that has gained widespread acceptance for the management of focal and generalized seizures. It…
Monograph of Topiramate
Introduction Definition and Overview Topiramate is a synthetic, orally administered antiepileptic drug that exhibits a broad spectrum of activity. It has gained…
Monograph of Lamotrigine
Introduction Definition and Overview Lamotrigine is a pyrrolobenzodiazepine derivative that functions primarily as a sodium channel blocker. It is widely employed in…
Monograph of Pregabalin
Introduction Definition and Overview Pregabalin is a structural analogue of the neurotransmitter γ‑aminobutyric acid (GABA) that functions as an anticonvulsant and analgesic…
Monograph of Gabapentin
Introduction Gabapentin, a structural analog of the inhibitory neurotransmitter gamma‑aminobutyric acid (GABA), was first approved by the United States Food and Drug…
Monograph of Zolpidem
Introduction Definition and Overview Zolpidem is a non‑benzodiazepine hypnotic agent that acts selectively as an agonist at the benzodiazepine recognition site of…